Perioperative Adebrelimab and Chemotherapy in Esophageal and Esophagogastric Junction Carcinoma
Conditions: Adebrelimab; Esophageal Cancer; Perioperative Period Interventions: Drug: adebrelimab,Paclitaxel,Lobaplatin,Fluorouracil Sponsors: Xijing Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Esophagus Cancer | Hospitals | Research